Description     Claims     Drawing  

US5168062A   [0091] 
US5385839A   [0091] 
US5122458A   [0092] 
EPO0273085A   [0110] 
WO0071096A   [0112] 
US20030203865A   [0112] 
US20020150626A   [0112] 
US20030032615A   [0112] 
US20040048787A   [0112] 
US5844107A   [0112] 
US5877302A   [0112] 
US6008336A   [0112] 
US6077835A   [0112] 
US5972901A   [0112] 
US6200801B   [0112] 
US5972900A   [0112] 
US5981505A   [0115] 
US6217900B   [0115] 
US6383512B   [0115] 
US5783565A   [0115] 
US7202227B   [0115] 
US6379965B   [0115] 
US6127170A   [0115] 
US5837533A   [0115] 
US6747014B   [0115] 
WO03093449A   [0115] 
WO2011038142A   [0124]  [0126] 
US20070173476A   [0127] 
US20050008617A   [0127] 
US20050014962A   [0127] 
US20050064595A   [0127] 
US20060008910A   [0127] 
US20060051405A   [0127] 
US20060083780A   [0127] 
US20050008689A   [0127] 
US20070172950A   [0127] 
US7101995B   [0127] 
US7220400B   [0127] 
US5705385A   [0127] 
US5965542A   [0127] 
US6287591B   [0127] 
US6815432B   [0128] 
US6586410B   [0128] 
US6534484B   [0128] 

Nature   [0002] 
Oncogene   [0002] 
Nature Medicine   [0002] 
Anal Chem.   [0002]  [0002] 
Nature Reviews. Drug Discovery   [0002]  [0002] 
Nucleic Acids Research   [0002] 
Nucleic Acids Research   [0002] 
Nucleic Acids Research   [0002] 
Nucleic Acids Research   [0002] 
PloS One   [0002] 
Nature   [0002] 
Methods in Molecular Biology   [0002] 
Nature Methods   [0002] 
Nature Protocols   [0002] 
Nucleic Acids Research   [0002] 
BMC Biotechnology   [0002] 
A mammalian herpesvirus Uses Noncanonical Expression and processing mechanisms to Generate Viral MicroRNAs   [0003] 
Identification of novel microRNA-like molecules generated from herpesvirus and host tRNA transcripts   [0003] 
Molecular Cloning: A Laboratory Manual   [0021] 
Current Protocols in Molecular Biology   [0021] 
Compilation of tRNA sequences and sequences of tRNA genes   [0062] 
Eur. J Cancer   [0075]  [0078] 
Mol Cancer Ther.   [0078] 
Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer   [0078] 
Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101   [0078] 
Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice.   [0078] 
The FoxA factors in organogenesis and differentiation.   [0078] 
Anterior gradient 2: A novel player in tumor cell biology.   [0078] 
Proc Natl Acad Sci USA   [0083] 
Proc Natl Acad Sci USA   [0083] 
Genes Dev.   [0083] 
EMBO J.   [0091] 
Proc. Natl. Acad. Sci. USA   [0091] 
Cell   [0091] 
J. Virol.   [0092] 
Experimental Biology and Medicine   [0111] 
Journal of Virology   [0111] 
Remington's Pharmaceutical Sciences   [0120] 
Remington: the Science & Practice of Pharmacy   [0130] 
Knocking down disease with siRNAs   [0178] 
RNA-based therapeutics: current progress and future prospects   [0178] 
RNA therapeutics: beyond RNA interference and antisense oligonucleotides   [0178] 
DNA and RNA aptamers: from tools for basic research towards therapeutic applications   [0178] 
Quantification of therapeutic miRNA mimics in whole blood from non-human primates   [0178] 
MicroRNAs and other noncoding RNAs as targets for anticancer drug development   [0178] 
In vitro optimization of 2'-Ome-4'-thioribonucleoside-modified anti-microRNA oligonucleotides and its targeting delivery to mouse liver using a liposomal nanoparticle   [0178] 
Miravirsen (SPC3649) can inhibit the biogenesis of miR-122   [0178] 
Aptamers switch on fluorescence of triphenylmethane dyes   [0178] 
Synthesis of RNA by in vitro transcription   [0178] 
Synthesis of biotin-AMP conjugate for 5' biotin labeling of RNA through one-step in vitro transcription   [0178] 
Efficient and specific gene knockdown by small interfering RNAs produced in bacteria   [0178] 
Recombinant RNA technology: the tRNA scaffold   [0178] 
A generic protocol for the expression and purification of recombinant RNA in Escherichia coli using a tRNA scaffold   [0178] 
Fast production of homogeneous recombinant RNA-towards large-scale production of RNA   [0178] 
DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli   [0178] 
Rapid Production of Novel Pre-MicroRNA Agent has-mir-27b in Escherichia coli Using Recombinant RNA Technology for Functional Studies in Mammalian Cells   [0178] 
CENTROIDFOLD: a web server for RNA secondary structure prediction   [0178] 
CentroidHomfold-LAST: accurate prediction of RNA secondary structure using automatically collected homologous sequences   [0178] 
Cytomegalovirus microRNA expression is tissue specific and is associated with persistence   [0178] 
Novel and conserved micrornas in Dalian purple urchin (Strongylocentrotus nudus) identified by next generation sequencing   [0178] 
N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis   [0178] 
Small nucleolar RNA-derived microRNA has-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1   [0178] 
Green mice' as a source of ubiquitous green cells   [0178] 
Generation of hairpin-based RNAi vectors for biological and therapeutic application   [0178] 
A functional study of miR-124 in the developing neural tube   [0178] 
microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling   [0178] 
An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis   [0178] 
Elevated serum ribonuclease in patients with pancreatic cancer   [0178] 
Purification and properties of alkaline ribonuclease from human serum   [0178] 
The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo   [0178] 
Deep sequencing of small RNAs identifies canonical and non-canonical miRNA and endogenous siRNAs in mammalian somatic tissues   [0178] 
microRNAs associated with the different human Argonaute proteins   [0178] 
Crystalline desoxyribonuclease; isolation and general properties; spectrophotometric method for the measurement of desoxyribonuclease activity   [0178] 
Spectrophotometric assay of bovine pancreatic ribonuclease by the use of cytidine 2':3'-phosphate   [0178] 
Serum Rnase in the diagnosis of pancreatic carcinoma   [0178] 
Hybridase activity of human ribonuclease-1 revealed by a real-time fluorometric assay   [0178] 
Serum ribonuclease activity in cancer patients   [0178] 
Characterization and selectivity of catalytic antibodies from human serum with Rnase activity   [0178] 
Increased N-glycosylation of Asn(8)(8) in serum pancreatic ribonuclease 1 is a novel diagnostic marker for pancreatic cancer   [0178] 
Rapid tRNA decay can result from lack of nonessential modifications   [0213]  [0257] 
The promise of microRNA replacement therapy   [0213] 
N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis   [0213]  [0257] 
MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland   [0213] 
Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress   [0213] 
Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators Foxa1 and Foxa2   [0213] 
The RNA Modification Database, RNAMDB: 2011 update   [0213] 
A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications   [0213]  [0257] 
ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development   [0213] 
Analysis of chromatin-immunopurified MeCP2-associated fragments   [0213] 
Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis   [0213] 
Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group   [0213] 
Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development   [0213] 
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma   [0213] 
Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379   [0213] 
Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma   [0213] 
Mass spectrometry-based detection of transfer RNAs by their signature endonuclease digestion products   [0213] 
Multiple endonucleases improve MALDI-MS signature digestion product detection of bacterial transfer RNAs   [0213] 
Removal of 3'-phosphate group by bacterial alkaline phosphatase improves oligonucleotide sequence coverage of Rnase digestion products analyzed by collision-induced dissociation mass spectrometry   [0213] 
Evolving role of MeCP2 in Rett syndrome and autism   [0213] 
Rapid Production of Novel Pre-MicroRNA Agent has-mir-27b in Escherichia coli Using Recombinant RNA Technology for Functional Studies in Mammalian Cells   [0213] 
Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (has-miR-328, -519c and - 520h) and their differential expression in stem-like ABCG2+ cancer cells   [0213] 
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1   [0213] 
Summary: the modified nucleosides of RNA   [0213] 
Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells   [0213] 
DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli   [0213] 
ABCC4 is regulated by microRNA-124a and microRNA-506   [0213] 
Fast production of homogeneous recombinant RNA-towards large-scale production of RNA   [0213] 
MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells   [0213] 
Small nucleolar RNA-derived microRNA has-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1   [0213] 
Analysis of RNA hydrolyzates by liquid chromatography-mass spectrometry   [0213] 
A generic protocol for the expression and purification of recombinant RNA in Escherichia coli using a tRNA scaffold   [0213]  [0257] 
Recombinant RNA technology: the tRNA scaffold   [0213]  [0257] 
Epigenetic regulation by Z-DNA silencer function controls cancer-associated ADAM-12 expression in breast cancer: cross-talk between MeCP2 and NF1 transcription factor family   [0213] 
Evaluating the reproducibility of quantifying modified nucleosides from ribonucleic acids by LC-UV-MS   [0213]  [0257] 
Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer   [0213] 
Top-down mass spectrometry for sequencing of larger (up to 61 nt) RNA by CAD and EDD   [0213] 
Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line   [0213] 
MicroRNAs as potential cancer therapeutics   [0213] 
Functional role of methylation of G518 of the 16S rRNA 530 loop by GidB in Mycobacterium tuberculosis   [0213] 
Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma   [0213] 
ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer   [0213] 
miR-34 - a microRNA replacement therapy is headed to the clinic   [0257] 
Differential regulation of hepatic organic cation transporter 1, organic anion-transporting polypeptide 1a4, bile-salt export pump, and multidrug resistance-associated protein 2 transporter expression in lymphocyte-deficient mice associates with interleukin-6 production   [0257] 
Reexamination of the effect of endotoxin on cell proliferation and transfection efficiency   [0257] 
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis   [0257] 
Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition   [0257] 
Gene expression signature of human HepG2 cell line   [0257] 
Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo   [0257] 
A microRNA component of the p53 tumour suppressor network   [0257] 
p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines   [0257] 
Efficient and specific gene knockdown by small interfering RNAs produced in bacteria   [0257] 
Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport   [0257] 
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy   [0257] 
miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma   [0257] 
Quantification of therapeutic miRNA mimics in whole blood from non-human primates   [0257] 
Removal of 3'-phosphate group by bacterial alkaline phosphatase improves oligonucleotide sequence coverage of RNase digestion products analyzed by collision-induced dissociation mass spectrometry   [0257] 
A novel class of small RNAs: tRNA-derived RNA fragments (tRFs)   [0257] 
p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines   [0257] 
Chimeric miR-1291 biosynthesized efficiently in E. coli is effective to reduce target gene expression in human carcinoma cells and improve chemosensitivity   [0257] 
Rapid Production of Novel Pre-MicroRNA Agent hsa-mir-27b in Escherichia coli Using Recombinant RNA Technology for Functional Studies in Mammalian Cells   [0257] 
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes   [0257] 
Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs   [0257] 
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44   [0257] 
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer   [0257] 
Fast production of homogeneous recombinant RNA--towards large-scale production of RNA   [0257] 
Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis   [0257] 
A role for tRNA modifications in genome structure and codon usage   [0257] 
Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1   [0257] 
Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice   [0257] 
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest   [0257] 
Top-down mass spectrometry for sequencing of larger (up to 61 nt) R A by CAD and EDD   [0257] 
Curcumin analog L48H37 prevents LPS-induced TLR4 signaling pathway activation and sepsis via targeting MD2   [0257] 
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells   [0257] 
Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34   [0257] 
miR-34a repression of SIRT1 regulates apoptosis   [0257] 
Epigenetic modifications in fibrotic diseases: implications for pathogenesis and pharmacological targets   [0257] 
Role of microRNAs in the regulation of drug metabolism and disposition   [0257]